IHS Chemical Week

People & Business :: M&A

Novozymes completes acquisition of Iogen’s industrial enzyme business

7:06 AM MST | February 25, 2013 | Deepti Ramesh

Novozymes and Iogen (Ottawa, ON) say that the previously announced acquisition of Iogen Bio-Products, the industrial enzyme business of Iogen, by Novozymes has been completed. It was announced on 31 January that Novozymes would acquire Iogen Bio-Products for C$67.5 million ($66 million) and potential earn-out payments of up to C$12.5 million. The closing conditions for the transaction have been met, and the acquisition has been completed, the companies say. Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa